Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 9H-Purin-6-amine, 9-β-D-arabinofuranosyl-, hydrate (1:1)

9H-Purin-6-amine, 9-β-D-arabinofuranosyl-, hydrate (1:1)

9H-Purin-6-amine, 9-β-D-arabinofuranosyl-, hydrate (1:1) structure

9H-Purin-6-amine, 9-β-D-arabinofuranosyl-, hydrate (1:1) 

structure
  • CAS No:

    24356-66-9

  • Formula:

    C10H13N5O4.H2O

  • Chemical Name:

    9H-Purin-6-amine, 9-β-D-arabinofuranosyl-, hydrate (1:1)

  • Synonyms:

    9H-Purin-6-amine,9-β-D-arabinofuranosyl-,hydrate (1:1);Adenine,9-β-D-arabinofuranosyl-,monohydrate;9H-Purin-6-amine,9-β-D-arabinofuranosyl-,monohydrate;Adenine arabinofuranoside hydrate;Vidarabine monohydrate

  • Categories:

    Biochemical Engineering  >  Saccharides

Description

Vidarabine monohydrate is an adenine arabinoside.|Vidarabine is a nucleoside analog with activity against herpes simplex virus and varicella zoster virus. Vidarabine is converted to a monophosphate by viral thymidine kinase and is further modified to a triphosphate form by host enzymes. Vidarabine triphosphate directly inhibits DNA polymerase and also acts as a chain terminator in DNA replication.|A nucleoside antibiotic isolated from Streptomyces antibioticus. It has some antineoplastic properties and has broad spectrum activity against DNA viruses in cell cultures and significant antiviral activity against infections caused by a variety of viruses such as the herpes viruses, the VACCINIA VIRUS and varicella zoster virus.

9H-Purin-6-amine, 9-β-D-arabinofuranosyl-, hydrate (1:1) Basic Attributes

285.2566

285.10731860 g/mol

678-339-4

FA2DM6879K

C929

Characteristics

141 Ų

1.3439

253 °C

427.69°C (rough estimate)

-3.0 ° (C=1, DMF)

513.5mg/L(temperature not stated)

Safety Information

62

45-53-36/37

AU6200000

|Warning|H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]|P201, P202, P281, P308+P313, P405, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Drug Information

Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)|Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)

9 beta Arabinofuranosyladenine

9H-Purin-6-amine, 9-β-D-arabinofuranosyl-, hydrate (1:1) Use and Manufacturing

Antiviral.

Computed Properties

Molecular Weight:285.26
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:9
Rotatable Bond Count:2
Exact Mass:285.10731860
Monoisotopic Mass:285.10731860
Topological Polar Surface Area:141
Heavy Atom Count:20
Complexity:335
Defined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Recommended Suppliers of 9H-Purin-6-amine, 9-β-D-arabinofuranosyl-, hydrate (1:1)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.